TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Apr 16, 2026
2 min read
33

The Paris stock market closed with modest losses on Thursday, as the benchmark CAC 40 index declined by 0.14%. Similarly, the broader SBF 120 index edged down by 0.08%, reflecting a mixed trading session for French equities.
The downturn was primarily influenced by poor performance in key sectors. Significant losses were recorded in Utilities, Basic Materials, and Consumer Services, which pulled the main index lower. Despite the negative close for the index, market breadth was positive, with 262 stocks rising compared to 218 that fell, indicating specific pockets of strength within the market.
Among the worst performers on the CAC 40 were Safran SA, which dropped 3.43%, and luxury group Kering SA, which fell 3.07%. In contrast, Dassault Systemes SE led the gainers with a 3.05% increase. Meanwhile, the CAC 40 VIX, a measure of market volatility, held steady at a 52-week high, signaling heightened investor caution.
While the overall market registered a slight decline, the session was characterized by sector rotation rather than a broad-based sell-off. The elevated volatility suggests that investors remain watchful of economic indicators and global commodity price movements, which saw crude oil and gold futures trading higher.
Q: Which French stock market index is the main benchmark?
A: The CAC 40 is the primary benchmark index for the French stock market, tracking the 40 largest French stocks based on market capitalization.
Q: Which sectors were the weakest performers during the session?
A: The Utilities, Basic Materials, and Consumer Services sectors experienced the most significant losses, leading the market's decline.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

01 Mei 2026
Canada Approves Apotex Generic Ozempic Drug

01 Mei 2026
RRE Ventures SPAC Raises $250M in Nasdaq IPO